Stereotactic ablative body radiotherapy (SABR) is arising as a promising non-invasive alternative for the treatment of ventricular tachycardia. There are limited data concerning the radiobiologic changes occurring post-therapy. We report a challenging case of a patient undergoing a combined epicardial and endocardial ablation after SABR.